Contrary to RANKL and LIGHT, which appear to promote MASLD, tumor necrosis factor weak inducer of apoptosis (TWEAK) was shown to downregulate TNF-α-induced inflammatory signals and ameliorate IR and hepatic steatosis [54], thus implying a potentially beneficial effect in MASLD. Here, TNFSF11 is linked to metabolic dysfunction-associated steatotic liver disease.